Cargando…

Mobile application development for improving medication safety in tuberculosis patients: A quasi-experimental study protocol

The COVID-19 pandemic, the growth of smartphones, and the internet have driven the use of technology for monitoring TB patients. Innovation in management of TB patients is needed to improve treatment outcomes. The study was conducted to obtain a predictive model of medication safety and solution mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Wijayanti, Erlina, Bachtiar, Adang, Achadi, Anhari, Rachmawati, Ummi Azizah, Sjaaf, Amal Chalik, Eryando, Tris, Besral, Trihono, Siregar, Kemal N., Vidiawati, Dhanasari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451058/
https://www.ncbi.nlm.nih.gov/pubmed/36070321
http://dx.doi.org/10.1371/journal.pone.0272616
_version_ 1784784655307767808
author Wijayanti, Erlina
Bachtiar, Adang
Achadi, Anhari
Rachmawati, Ummi Azizah
Sjaaf, Amal Chalik
Eryando, Tris
Besral,
Trihono,
Siregar, Kemal N.
Vidiawati, Dhanasari
author_facet Wijayanti, Erlina
Bachtiar, Adang
Achadi, Anhari
Rachmawati, Ummi Azizah
Sjaaf, Amal Chalik
Eryando, Tris
Besral,
Trihono,
Siregar, Kemal N.
Vidiawati, Dhanasari
author_sort Wijayanti, Erlina
collection PubMed
description The COVID-19 pandemic, the growth of smartphones, and the internet have driven the use of technology for monitoring TB patients. Innovation in management of TB patients is needed to improve treatment outcomes. The study was conducted to obtain a predictive model of medication safety and solution model for at-risk patients, and to improve medication safety through mobile applications. The research was conducted in 4 stages, namely qualitative, quantitative (cross-sectional), qualitative, and quantitative (quasi-experimental, post-test group control design). Data were taken at the Public Health Center in Jakarta, Indonesia. Samples were taken by cluster random sampling. For quantitative research, 2(nd) phase (n = 114) and 4(th) phase (n = 96) were analyzed using logistic regression. This study analyzed predictors of medication safety to assist in monitoring patients undergoing treatment. At-risk patients were educated using an algorithm programmed in the application.
format Online
Article
Text
id pubmed-9451058
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-94510582022-09-08 Mobile application development for improving medication safety in tuberculosis patients: A quasi-experimental study protocol Wijayanti, Erlina Bachtiar, Adang Achadi, Anhari Rachmawati, Ummi Azizah Sjaaf, Amal Chalik Eryando, Tris Besral, Trihono, Siregar, Kemal N. Vidiawati, Dhanasari PLoS One Study Protocol The COVID-19 pandemic, the growth of smartphones, and the internet have driven the use of technology for monitoring TB patients. Innovation in management of TB patients is needed to improve treatment outcomes. The study was conducted to obtain a predictive model of medication safety and solution model for at-risk patients, and to improve medication safety through mobile applications. The research was conducted in 4 stages, namely qualitative, quantitative (cross-sectional), qualitative, and quantitative (quasi-experimental, post-test group control design). Data were taken at the Public Health Center in Jakarta, Indonesia. Samples were taken by cluster random sampling. For quantitative research, 2(nd) phase (n = 114) and 4(th) phase (n = 96) were analyzed using logistic regression. This study analyzed predictors of medication safety to assist in monitoring patients undergoing treatment. At-risk patients were educated using an algorithm programmed in the application. Public Library of Science 2022-09-07 /pmc/articles/PMC9451058/ /pubmed/36070321 http://dx.doi.org/10.1371/journal.pone.0272616 Text en © 2022 Wijayanti et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Study Protocol
Wijayanti, Erlina
Bachtiar, Adang
Achadi, Anhari
Rachmawati, Ummi Azizah
Sjaaf, Amal Chalik
Eryando, Tris
Besral,
Trihono,
Siregar, Kemal N.
Vidiawati, Dhanasari
Mobile application development for improving medication safety in tuberculosis patients: A quasi-experimental study protocol
title Mobile application development for improving medication safety in tuberculosis patients: A quasi-experimental study protocol
title_full Mobile application development for improving medication safety in tuberculosis patients: A quasi-experimental study protocol
title_fullStr Mobile application development for improving medication safety in tuberculosis patients: A quasi-experimental study protocol
title_full_unstemmed Mobile application development for improving medication safety in tuberculosis patients: A quasi-experimental study protocol
title_short Mobile application development for improving medication safety in tuberculosis patients: A quasi-experimental study protocol
title_sort mobile application development for improving medication safety in tuberculosis patients: a quasi-experimental study protocol
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451058/
https://www.ncbi.nlm.nih.gov/pubmed/36070321
http://dx.doi.org/10.1371/journal.pone.0272616
work_keys_str_mv AT wijayantierlina mobileapplicationdevelopmentforimprovingmedicationsafetyintuberculosispatientsaquasiexperimentalstudyprotocol
AT bachtiaradang mobileapplicationdevelopmentforimprovingmedicationsafetyintuberculosispatientsaquasiexperimentalstudyprotocol
AT achadianhari mobileapplicationdevelopmentforimprovingmedicationsafetyintuberculosispatientsaquasiexperimentalstudyprotocol
AT rachmawatiummiazizah mobileapplicationdevelopmentforimprovingmedicationsafetyintuberculosispatientsaquasiexperimentalstudyprotocol
AT sjaafamalchalik mobileapplicationdevelopmentforimprovingmedicationsafetyintuberculosispatientsaquasiexperimentalstudyprotocol
AT eryandotris mobileapplicationdevelopmentforimprovingmedicationsafetyintuberculosispatientsaquasiexperimentalstudyprotocol
AT besral mobileapplicationdevelopmentforimprovingmedicationsafetyintuberculosispatientsaquasiexperimentalstudyprotocol
AT trihono mobileapplicationdevelopmentforimprovingmedicationsafetyintuberculosispatientsaquasiexperimentalstudyprotocol
AT siregarkemaln mobileapplicationdevelopmentforimprovingmedicationsafetyintuberculosispatientsaquasiexperimentalstudyprotocol
AT vidiawatidhanasari mobileapplicationdevelopmentforimprovingmedicationsafetyintuberculosispatientsaquasiexperimentalstudyprotocol